A study on humans to understand the success of dental implants in controlled type 2 diabetic patients

Implant placement in controlled type 2 diabetic patients: A clinical and radiological evaluation.

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/01/011281

Enrollment

Registered

2018-01-11

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Mandibular partially edentulous patients with type 2 controlled diabetes

Interventions

Intervention1: Genesis RBM Implant system: Active implants with RBM Implant System, length: 8-11.5mm, width: 4.2-5mm Genesis Implant system, JJ dental corporation, vii/202 G Munipara, Chalakudy P.O, T

Eligibility

Inclusion criteria

Inclusion criteria: 1. Mandibular partially edentulous alveolar ridge patients with type 2 controlled diabetes and HBA1C less than 7

Exclusion criteria

Exclusion criteria: 1. Patients with systemic diseases other than type 2 diabetes. 2. Smokers 3. Patients with active periodontitis.

Design outcomes

Primary

Measure	Time frame
1. Probing depth around the implant 2. Crestal bone loss on medial and distal side of implantTimepoint: 1. Probing depth around the implant at 3 and 6 months 2. Crestal bone loss on medial and distal side of implant at 3 and 6 months	—

Secondary

Measure	Time frame
1. Plaque index 2. Gingival index 3. Bleeding on probingTimepoint: 1. Plaque index at baseline, 3 & 6 months 2. Gingival index at baseline, 3 & 6 months 3. Bleeding on probing at baseline, 3 & 6 months	—

Countries

India

Contacts

Public ContactDr P Seetha Lakshmi

Vishnu dental college

gautami_penmetsa@yahoo.co.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026